Document type
ArticleVersion
Published versionPublication date
All rights reserved
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/208377
Diffuse large B-cell lymphomas, not otherwise specified, and emerging entities
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
Diffuse large B-cell lymphoma (DLBCL) is an aggressive and heterogenous group of diseases and the most common subtype of non-Hodgkin lymphoma. In the past decade, there has been an explosion in molecular profiling that has helped to identify subgroups and shared oncogenic driving mechanisms. Since the 2017 World Health Organization (WHO) classification, additional studies investigating these genomic abnormalities and phenotypic findings have been reported. Here we review these findings in DLBCL and address the proposed changes by the 2022 International Consensus Classification.
Subject
Subject (English)
Citation
Citation
SONG, Joo Y., et al. Diffuse large B-cell lymphomas, not otherwise specified, and emerging entities. Virchows Archiv. 2023. Vol. 482, num. 1, pags. 179-192. ISSN 1432-2307. [consulted: 9 of June of 2026]. Available at: https://hdl.handle.net/2445/208377